Medication info
Sapoese Sustained Release Tablets (Sarpogrelate Hydrochloride)

Sapoese Sustained Release Tablets (Sarpogrelate Hydrochloride)

Prescription medicationTablet경구
Ingredient · strength
Sarpogrelate Hydrochloride›200mg / 1 tablet
Manufacturer / importer
현대약품(주)
Appearance
White oblong film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903507 · Approved 2019.05.28 · Insurance code 642004360

Summary

Main use
Improvement of ischemic symptoms in chronic arterial occlusion (ulcers, pain, etc.)
Who takes it
Adults
Adult dose
Administer Sarpogrelate Hydrochloride sustained-release tablets 300 mg orally once daily after meals. This medication should be taken whole, without chewing or breaking.

Ingredients

Manufacturer
현대약품(주)

Efficacy & effects

Improvement of ischemic symptoms in chronic arterial occlusion (ulcers, pain, etc.)

  • Chronic arterial occlusion
  • Buerger's disease
  • occlusive arterial sclerosis
  • diabetic peripheral vascular disease
  • ulcers
  • pain
  • cold sensation
  • ischemic symptoms
View approved original text

This medication is used to improve ischemic symptoms such as ulcers, pain, and feelings of coldness due to inadequate blood supply caused by chronic arterial occlusion. It helps alleviate vascular problems that arise from various causes such as Buerger's disease, occlusive arterial sclerosis, and diabetic peripheral vascular disease, aiding in the improvement of symptoms. Therefore, it is effective in reducing discomfort caused by these diseases and restoring normal blood circulation.

How to take

Adult dose

Administer Sarpogrelate Hydrochloride sustained-release tablets 300 mg orally once daily after meals. This medication should be taken whole, without chewing or breaking.

Precautions

This drug should not be used in patients with bleeding, as it may increase the risk of bleeding. Special caution is required in cases of hemophilia, capillary abnormalities, gastrointestinal ulcers, urinary bleeding, hemoptysis, or spontaneous bleeding. It is advisable not to administer this medication to pregnant women or those who may become pregnant, as it may harm the fetus. Patients who are menstruating or have a tendency to bleed should use it with caution, as the risk of bleeding may increase. Patients taking anticoagulants or platelet aggregation inhibitors should be cautious, as the risk of bleeding may increase. Patients with severe renal impairment should receive careful dosing as it may affect drug excretion. Elderly individuals may experience adverse reactions more readily, necessitating caution. While taking this medication, various side effects such as urticaria, dyspepsia, diarrhea, headache, cough, and blood pressure changes may occur, so any abnormal symptoms should be reported to medical personnel immediately. If symptoms of bleeding, blood abnormalities, or liver dysfunction occur, the use of the medication should be discontinued immediately and medical personnel should be consulted. Regular blood tests are advisable to monitor for adverse reactions. Additionally, this drug may heighten the risk of bleeding when taken with anticoagulants or platelet aggregation inhibitors, so caution is required during co-administration. Pregnant or lactating women are advised not to take this medication, and if it is absolutely necessary, breastfeeding should be avoided. Safety for pediatric use has not been established, so it is best not to use it. Finally, keep this medication out of reach of children, and do not transfer it to another container, as this ensures safety and helps maintain the quality of the drug.

Side effects and when to seek care immediately

Serious side effects

Urticaria, gastrointestinal bleeding (hematemesis and melena, etc.), cerebral hemorrhage, subcutaneous bleeding, agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, erythema, rash, itching, respiratory distress, palpitations, chest pain, angina, exacerbation of coronary artery disease, myocardial infarction, cerebral infarction, stroke, deterioration of renal function, hematemesis, gastric perforation, intestinal obstruction

Mild side effects

  • Pharyngitis
  • conjunctivitis
  • upper respiratory infection
  • dyspepsia
  • constipation
  • diarrhea
  • gastritis
  • gastrointestinal dysfunction
  • hypoglycemia
  • decreased appetite
Show 25 more
  • back pain
  • muscle weakness
  • headache
  • sensory disturbances
  • cough
  • blood pressure fluctuations
  • atrial fibrillation
  • anxiety
  • urinary difficulty
  • chills
  • warmth
  • fever
  • wound
  • bruise
  • dizziness
  • carpal tunnel syndrome
  • spinal stenosis
  • diabetic foot ulcer
  • foot ulcer
  • warts
  • onychomycosis
  • eczema
  • alopecia areata
  • roseola
  • contact dermatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.